Your browser doesn't support javascript.
loading
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
Butzkueven, Helmut; Spelman, Tim; Horakova, Dana; Hughes, Stella; Solaro, Claudio; Izquierdo, Guillermo; Kubala Havrdová, Eva; Grand'Maison, Francois; Prat, Alexandre; Girard, Marc; Hupperts, Raymond; Onofrj, Marco; Lugaresi, Alessandra; Taylor, Bruce; Giovannoni, Gavin; Kappos, Ludwig; Hauser, Stephen L; Montalban, Xavier; Craveiro, Licinio; Freitas, Rita; Model, Fabian; Overell, James; Muros-Le Rouzic, Erwan; Sauter, Annette; Wang, Qing; Wormser, David; Wolinsky, Jerry S.
Affiliation
  • Butzkueven H; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Spelman T; Department of Medicine and Melbourne Brain Centre, The Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.
  • Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Hughes S; Department of Neurology, Craigavon Area Hospital, Craigavon, UK.
  • Solaro C; Belfast Health and Social Care Trust, Belfast, UK.
  • Izquierdo G; CRRF "Mons. Luigi Novarese", Moncrivello, (VC), Italy.
  • Kubala Havrdová E; Vithas Nisa Hospital, Seville, Spain.
  • Grand'Maison F; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University, Prague, Czech Republic.
  • Prat A; Neuro Rive-Sud, Quebec City, Quebec, Canada.
  • Girard M; CHUM and Universite de Montreal, Montreal, Quebec, Canada.
  • Hupperts R; CHUM and Universite de Montreal, Montreal, Quebec, Canada.
  • Onofrj M; Zuyderland Ziekenhuis, Sittard, The Netherlands.
  • Lugaresi A; University G. d'Annunzio, Chieti, Italy.
  • Taylor B; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, Italy.
  • Giovannoni G; Royal Hobart Hospital, Hobart, Tasmania, Australia.
  • Hauser SL; Queen Mary University of London, London, UK.
  • Montalban X; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Craveiro L; University of California, San Francisco, California, USA.
  • Freitas R; Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Model F; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Overell J; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Muros-Le Rouzic E; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Sauter A; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Wang Q; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Wormser D; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Wolinsky JS; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Eur J Neurol ; 29(4): 1082-1090, 2022 04.
Article in En | MEDLINE | ID: mdl-33724638
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wheelchairs / Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wheelchairs / Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: Australia